Login
Register
Back to News
Xencor shares are trading lower after Alexion Pharmaceuticals informed the company it does not owe additional royalties for Ultomiris sales in the U.S.
Benzinga Newsdesk
www.benzinga.com
Negative 96.9%
Neg 96.9%
Neu 0%
Pos 0%
Comments
No comments yet. Be the first!
Join the discussion
Login to comment
Login to comment